Radiopharmaceuticals

"Radiopharmaceuticals" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161)

Descriptor ID	D019275
MeSH Number(s)	D27.505.259.843 D27.505.519.871 D27.720.470.410.650
Concept/Terms	Radiopharmaceuticals Radiopharmaceuticals

Below are MeSH descriptors whose meaning is more general than "Radiopharmaceuticals".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Diagnostic Uses of Chemicals [D27.505.259]
Radiopharmaceuticals [D27.505.259.843]
Molecular Mechanisms of Pharmacological Action [D27.505.519]
Radiopharmaceuticals [D27.505.519.871]
Specialty Uses of Chemicals [D27.720]
Laboratory Chemicals [D27.720.470]
Indicators and Reagents [D27.720.470.410]
Radiopharmaceuticals [D27.720.470.410.650]

Below are MeSH descriptors whose meaning is related to "Radiopharmaceuticals".

Below are MeSH descriptors whose meaning is more specific than "Radiopharmaceuticals".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Radiopharmaceuticals" by people in this website by year, and whether "Radiopharmaceuticals" was a major or minor topic of these publications.

Bar chart showing 162 publications over 30 distinct years, with a maximum of 12 publications in 2003

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	3	2	5
1998	3	1	4
1999	4	1	5
2000	1	3	4
2001	7	2	9
2002	3	2	5
2003	3	9	12
2004	3	6	9
2005	0	2	2
2006	4	4	8
2007	1	8	9
2008	2	6	8
2009	3	7	10
2010	3	4	7
2011	3	5	8
2012	0	3	3
2013	4	3	7
2014	1	3	4
2015	2	1	3
2016	2	4	6
2017	1	5	6
2018	1	2	3
2019	1	2	3
2020	1	2	3
2021	2	3	5
2022	1	2	3
2023	0	2	2
2024	2	3	5
2025	1	0	1
2026	0	3	3

Below are the most recent publications written about "Radiopharmaceuticals" by people in Profiles.

Dorbala S, Maurer MS, Cuddy SAM, Auer BD, Kijewski MF, Clerc OF, Khouri MG, Mitchell JD, Sperry BW, Hanna M, AbouEzzeddine OF, Malhotra S, Wall JS, Guthrie S, Di Carli MF, Ruberg FL, Dilsizian V, Dispenzieri A, Udelson JE, Narra RK, Masri AM. Design and rationale of the Research with EVuzamitide to Evaluate for cardiac AmyLoidosis (REVEAL) positron emission tomography study: A study of 124I-evuzamitide to diagnose cardiac amyloidosis. J Nucl Cardiol. 2026 Jul; 61:102773.

View in: PubMed
Miller RJ, Clerc OF, Cuddy SA, Auer B, Kijewski MF, Miller EJ, Slomka PJ, Dorbala S. Quantitative cardiac amyloid radionuclide imaging. J Nucl Cardiol. 2026 May; 59S:102724.

View in: PubMed
Chang SD, Jeavons C, Ulaner GA, Purysko AS, Caserta MP, Catanzano TM, De Leon AD, Lew SQ, Nicola R, Raj N, Refaat T, Ristau BT, Schultz D, Sol?rzano CC, Surabhi VR, Taffel MT, Khatri G. ACR Appropriateness Criteria? Staging and Follow-Up of Adrenal Cancer. J Am Coll Radiol. 2026 Aug; 23(8):1675-1686.

View in: PubMed
Yusufaly T, Roncali E, Brosch-Lenz J, Uribe C, Jha AK, Currie G, Dutta J, El-Fakhri G, McMeekin H, Pandit-Taskar N, Schwartz J, Shi K, Strigari L, Zaidi H, Saboury B, Rahmim A. Computational Nuclear Oncology Toward Precision Radiopharmaceutical Therapies: Current Tools, Techniques, and Uncharted Territories. J Nucl Med. 2025 04 01; 66(4):509-515.

View in: PubMed
Trinh K, Chow DZ, Park H, Habib U, Offit L, Franquet E, Almeida RR, Wang Y, Borges N, Jamal F, Jacene HA, Heidari P, Ng TSC. Evaluating the Added Value of Concurrent Contrast-enhanced Diagnostic CT for PSMA-PET/CT Interpretation. Acad Radiol. 2025 01; 32(1):275-286.

View in: PubMed
Vijayakumar S, Pabon AR, Clerc OF, Cuddy SAM, Gu Y, Watts C, Sullivan K, Auer B, Kijewski MF, DiCarli MF, Falk RH, Dorbala S. Quantitative 99mTc-pyrophosphate myocardial uptake: Changes on transthyretin stabilization therapy. J Nucl Cardiol. 2024 Sep; 39:102019.

View in: PubMed
Bourque JM, Birgersdotter-Green U, Bravo PE, Budde RPJ, Chen W, Chu VH, Dilsizian V, Erba PA, Gallegos Kattan C, Habib G, Hyafil F, Khor YM, Manlucu J, Mason PK, Miller EJ, Moon MR, Parker MW, Pettersson G, Schaller RD, Slart RHJA, Strom JB, Wilkoff BL, Williams A, Woolley AE, Zwischenberger BA, Dorbala S. 18F-FDG PET/CT and Radiolabeled Leukocyte SPECT/CT Imaging for the Evaluation of Cardiovascular Infection in the Multimodality Context: ASNC Imaging Indications (ASNC I2) Series Expert Consensus Recommendations From ASNC, AATS, ACC, AHA, ASE, EANM, HRS, IDSA, SCCT, SNMMI, and STS. JACC Cardiovasc Imaging. 2024 Jun; 17(6):669-701.

View in: PubMed
Bourque JM, Birgersdotter-Green U, Bravo PE, Budde RPJ, Chen W, Chu VH, Dilsizian V, Erba PA, Gallegos Kattan C, Habib G, Hyafil F, Khor YM, Manlucu J, Mason PK, Miller EJ, Moon MR, Parker MW, Pettersson G, Schaller RD, Slart RHJA, Strom JB, Wilkoff BL, Williams A, Woolley AE, Zwischenberger BA, Dorbala S. 18F-FDG PET/CT and radiolabeled leukocyte SPECT/CT imaging for the evaluation of cardiovascular infection in the multimodality context: ASNC Imaging Indications (ASNC I2) Series Expert Consensus Recommendations from ASNC, AATS, ACC, AHA, ASE, EANM, HRS, IDSA, SCCT, SNMMI, and STS. Heart Rhythm. 2024 05; 21(5):e1-e29.

View in: PubMed
Walker SM, Schneider A, Olulade O, Zabel T, Wakefield C, Auer B, Barletta JA, Marqusee E, Shah H. Illustrative Review of Nuclear Medicine Thyroid Studies. Radiographics. 2024 02; 44(2):e230095.

View in: PubMed
Emperumal CP, Villa A, Hwang C, Oh D, Fong L, Aggarwal R, Keenan BP. Oral Toxicities of PSMA-Targeted Immunotherapies for The Management of Prostate Cancer. Clin Genitourin Cancer. 2024 04; 22(2):380-384.

View in: PubMed

People

Explore

Similar Concepts

Top Journals